(Q28238709)

1

0 references

Nea Pitulis

2

0 references

Pavlos Msaouel

3

0 references

Peter Lembessis

4

0 references

Michael Koutsilieris

Expert Opinion on Therapeutic Targets

5

0 references

language of work or name

English

0 references

publication date

August 2007

0 references

published in

0 references

volume

11

0 references

issue

8

0 references

page(s)

1071-85

0 references

cites work

Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling

1 reference

https://api.crossref.org/works/10.1517/14728222.11.8.1071

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.11.8.1071

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.11.8.1071

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.11.8.1071

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14728222.11.8.1071

The steroid and thyroid hormone receptor superfamily

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Phosphorylation of PPARs: from molecular characterization to physiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Human fatty-acid synthase gene. Evidence for the presence of two promoters and their functional interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The many faces of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

A nuclear receptor to prevent colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Thiazolidinediones: a new class of antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Hepatotoxicity of the thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The pleiotropic functions of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

PPAR gamma and the treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Selective activation of PPARgamma in breast, colon, and lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The Molecular Pharmacology of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliferator-activated receptor gamma in malignant diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

APC-dependent suppression of colon carcinogenesis by PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Terminal differentiation of human breast cancer through PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

PPAR gamma signaling exacerbates mammary gland tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Troglitazione affects survival of human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

MAP kinases in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

New insights into the control of MAP kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activated Raf-1 causes growth arrest in human small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Role of ERK in hydrogen peroxide-induced cell death of human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Modulating nuclear receptor function: may the phos be with you

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Interdomain communication regulating ligand binding by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Rapid, nongenomic steroid actions: A new age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive ox

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

The Akt pathway: molecular targets for anti-cancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Suppression of prostaglandin E2 receptor subtype EP2 by PPARgamma ligands inhibits human lung carcinoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Synergy between PPARgamma ligands and platinum-based drugs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Chromosomal Localization and Partial Genomic Structure of the Human Peroxisome Proliferator Activated Receptor-Gamma (hPPARγ) Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Peroxisome proliterator-activated receptors, orphans with ligands and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1071